Real-world efficacy and safety of luspatercept and predictive factors of response in patients with transfusion-dependent β-thalassemia.
Panzieri DL, Consonni D, Scaramellini N, Ausenda G, Granata F, Caponio N, Duca L, Leoni S, Elli S, Ferraresi M, Bolis V, Curcio C, Irrera MA, Maira D, Graziadei G, Cassinerio E, Cappellini MD, Bou-Fakhredin R, Brancaleoni V, Motta I.
Panzieri DL, et al. Among authors: leoni s.
Am J Hematol. 2024 Dec;99(12):2395-2398. doi: 10.1002/ajh.27474. Epub 2024 Sep 12.
Am J Hematol. 2024.
PMID: 39264036
No abstract available.